Cogent Biosciences, Inc. (COGT) /
The profitability of Cogent Biosciences, Inc. over the past 9 years
Chart Cogent Biosciences, Inc.: operating income, net income, fiscal 2017–2025 Open the chart →Cogent Biosciences, Inc. reported a net loss of $328.94M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $333.36M. It reported a loss in all 9 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$333.36M | -$328.94M |
| 2024ended Dec 31, 2024 | -$275.94M | -$255.86M |
| 2023ended Dec 31, 2023 | -$208.13M | -$192.41M |
| 2022ended Dec 31, 2022 | -$147.84M | -$140.24M |
| 2021ended Dec 31, 2021 | -$75.55M | -$72.27M |
| 2020ended Dec 31, 2020 | -$82.2M | -$74.81M |
| 2019ended Dec 31, 2019 | -$32.18M | -$31.83M |
| 2018ended Dec 31, 2018 | -$36.01M | -$34.53M |
| 2017ended Dec 31, 2017 | -$26.15M | -$25.49M |
Fiscal years as Cogent Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Cogent Biosciences, Inc.
- The revenue of Cogent Biosciences, Inc.
- The cash flow of Cogent Biosciences, Inc.
- The debt of Cogent Biosciences, Inc.
- All of Cogent Biosciences, Inc.'s financials, charted
Companies of a similar size
- RITMRithm Capital Corp.
- IBPInstalled Building Products, Inc.
- AMTMAmentum Holdings, Inc.
- PSNParsons Corporation
- PECOPhillips Edison & Company, Inc.
Not investment advice. This page shows what Cogent Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.